Biodegradable and Renal Clearable Inorganic Nanoparticles

Abstract

Personalized treatment plans for cancer therapy have been at the forefront of oncology research for many years. With the advent of many novel nanoplatforms, this goal is closer to realization today than ever before. Inorganic nanoparticles hold immense potential in the field of nano‐oncology, but have considerable toxicity concerns that have limited their translation to date. In this review, an overview of emerging biologically safe inorganic nanoplatforms is provided, along with considerations of the challenges that need to be overcome for cancer theranostics with inorganic nanoparticles to become a reality. The clinical and preclinical studies of both biodegradable and renal clearable inorganic nanoparticles are discussed, along with their implications.

Cited by papers we hold 5

• Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment · 2022
  No notice
• Cell Membrane-Coated Mimics: A Methodological Approach for Fabrication, Characterization for Therapeutic Applications, and Challenges for Clinical Translation · 2021
  No notice
• Photo-responsive degradable hollow mesoporous organosilica nanoplatforms for drug delivery · 2020
  Not checked
• Ultrabright gap-enhanced Raman tags for high-speed bioimaging · 2019
  No notice
• Advances in biodegradable nanomaterials for photothermal therapy of cancer · 2016
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.